RetinalGenix Technologies Inc. - 10-Q Filing

RetinalGenix Technologies reports $0 revenue for Q3 2026 with a net loss of $433,025 and cash reserves depleted to $5.

SEC EDGAR ·

Tickers: $RTGN

Read the full article at SEC EDGAR

More Regulatory news